NCT06910436

Brief Summary

The present study is practice-driven and merely observational and prospective. In clinical routine, patients who suffer from suspected ACS and do not show ST elevation in the ECG, different timing proposals in the guidelines and logistically driven differences lead to considerably variable timings in invasive coronary anatomy assessments. This handling may lead to larger infarct sizes when OMI is overseen. Therefore, the present study aims to observe a) whether an AI model is capable of correctly identify OMI in eligible patients and b) if in these patients troponin peak levels vary depending on the elapsed time between OMI diagnosis and coronary intervention. As the model has not been established yet clinically and in the guidelines, it is safe to assume the usual pathway from first medical contact to specialist's attention is undertaken. When a patient presents in an emergency department or places an emergency call, the physicians assess the situation as usal and as stated in the current guidelines1. If no STEMI is confirmed, the NSTE-ACS protocol is started. The patients who are ruled out for ACS are excluded from the final analysis (screening). In this case, the AI model is tested on their ECG in order to assess whether there are false positives. The patients which are in the ACS "rule-in" trail and undergo final coronary angiography will naturally be divided in patients which were classified as OMI and as non-OMI by the AI model. Furthermore, they will present a different "Time from OMI diagnosis to PCI) and variable troponin peak levels. By leveraging this natural variability, a practical distinction and multiple analyses can be done:

  1. 1.The feasibility of AI-powered ECG interpretation in the care of patients with suspected ACS and without clear ST-elevation infarction
  2. 2.The accuracy of AI-powered ECG interpretation in detecting OMI compared to the classical STEMI criteria
  3. 3.How infarct size correlates with different ECG readings by AI and (hypothesis generating) if changing the clinical practice could lead to a benefit in patients with suspected OMI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
2mo left

Started Apr 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Apr 2024Jul 2026

Study Start

First participant enrolled

April 1, 2024

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

2.3 years

First QC Date

March 28, 2025

Last Update Submit

April 16, 2026

Conditions

Keywords

Artificial IntelligenceECGAINSTE-ACSACSAcute Coronary SyndromeReperfusion timesPCIPercutaneous Coronary Intervention

Outcome Measures

Primary Outcomes (2)

  • Cardiovascular Mortality

    Cardiovascular Mortality

    12 months

  • Infarct Size

    Infarct size measured by transthoracic echocardiogram or cardiac magnetic resonance imaging

    12 months

Other Outcomes (1)

  • Performance of AI-based OMI detection

    Periprocedural (at the time of coronary angiography)

Study Arms (1)

NSTE-ACS

Patients with Non ST-Elevation myocardial infarction

Diagnostic Test: Coronary Angiogram

Interventions

Coronary AngiogramDIAGNOSTIC_TEST

Diagnostic/therapeutic procedure to reopen an occluded coronary artery by inflating a balloon and inserting a stent

NSTE-ACS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients presenting with chest pain and deemed as Non-ST Elevation Myocardial Infarction by the specialist, whether in the emergency medicine setting or in-hospital

You may qualify if:

  • Age \> 18 yrs
  • Working diagnosis of Non- ST Elevation Acute Coronary Syndrome after the assessment by specialist

You may not qualify if:

  • ST-Elevation Myocardial infarction
  • Age \< 18 yrs
  • Major sustained ventricular arrhythmias
  • Corrupted ECG images
  • Poor digitalisation quality of the ECG

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Sanitaria di Bolzano

Bolzano, BZ, 39100, Italy

RECRUITING

MeSH Terms

Conditions

Acute Coronary Syndrome

Interventions

Coronary Angiography

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisAngiographyRadiographyDiagnostic Techniques, CardiovascularHeart Function Tests

Central Study Contacts

Matthias Unterhuber, MD, Associate Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof. Dr.med. Dr. Med.univ. Matthias Unterhuber

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 4, 2025

Study Start

April 1, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

The trial is investigator initiated and patient privacy is of paramount importance.

Locations